Previous Article | Next Article ![]()
Infection and Immunity, December 2005, p. 7827-7835, Vol. 73, No. 12
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.12.7827-7835.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Department of Infectious Diseases,1 Department of Molecular Biotechnology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105,3 Department of Molecular Sciences, University of Tennessee Health Science Center, Memphis, Tennessee 381632
Received 26 April 2005/ Returned for modification 10 June 2005/ Accepted 1 September 2005
Pneumococci traverse eukaryotic cells within vacuoles without intracytoplasmic multiplication. The platelet-activating factor receptor (PAFr) has been suggested as a portal of entry. Pneumococci colocalized with PAFr on endothelial cells and PAFr/ mice showed a substantially impaired ability to support bacterial translocation, particularly from blood to brain. Pneumococci-induced colocalization of PAFr and ß-arrestin 1 at the plasma membrane of endothelial cells and PAFr-mediated pneumococcal uptake in transfected COS cells were greatly increased by cotransfection with the scaffold/adapter protein ß-arrestin 1. Activation of extracellular signal-regulated kinase kinases was required for uptake and was limited to the cytoplasmic compartment, consistent with activation by ß-arrestin rather than PAFr. Uptake of the pneumococcal vacuole involved clathrin, and half the bacteria proceeded into vacuoles marked by Rab5 and later Rab7, the classical route to the lysosome. Overexpression of ß-arrestin in endothelial cells decreased colocalization with Rab7. We conclude that the association of ß-arrestin with the PAFr contributes to successful translocation of pneumococci.
Supplemental material for this article may be found at http://iai.asm.org/.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»